Comentário Editorial sobre Resultados Clínicos da Radioterapia Hipofracionada com 12 Frações para Câncer de Próstata Localizado de Baixo e Médio Risco

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Clinical Outcomes of Hypofractionated Radiotherapy With 12 Fraction for Low‐ and Intermediate‐Risk Localized Prostate Cancer· 2026 · 1 citations
2. Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery· 2024 · 16 citations
3. Efficacy and tolerability of hypofractionated and dose-boosted radiotherapy for localised prostate cancer: a systematic review and meta-analysis· 2026 · 1 citations
4. 21 years of Biologically Effective Dose· 2010 · 637 citations
5. A Randomized Trial Comparing Hypofractionated and Conventionally Fractionated Three-Dimensional External-Beam Radiotherapy for Localized Prostate Adenocarcinoma· 2009 · 44 citations